Tilray Brands (TLRY) News
Latest news and analysis
Cannabis Stocks Rally as DEA Moves Marijuana to Schedule III
AKAN surges alongside TLRY and CGC as federal rescheduling triggers sector-wide momentum with June 2026 hearing set to finalize broader cannabis reclassification.
Major Cannabis Stocks Plunge on Rescheduling Reality Check
TLRY, CGC, ACB, CRON, and OGI tumble as investors reassess limited impact of federal cannabis reclassification on Canadian operators and market fundamentals.
Cannabis Stocks Plunge as Rescheduling Optimism Fades
Major cannabis operators including TLRY, CGC, and ACB tumble as investors reassess limited impact from federal reclassification prospects.
TLRY Stock Plunges 19% as Cannabis Sector Faces Mounting Pressure
Tilray Brands shares tumble amid broader cannabis market selloff, raising questions about sector fundamentals and investor appetite for marijuana stocks.
Cannabis Stocks Whipsaw on Federal Rescheduling Uncertainty
TLRY and cannabis equities experience volatile trading as investors parse mixed signals on federal marijuana policy changes and regulatory timeline.
Cannabis Giants TLRY, CGC Rally on Federal Policy Breakthrough
Major cannabis stocks surge as Washington delivers long-awaited regulatory shift, sending Tilray and Canopy Growth shares climbing on institutional optimism.
TLRY Surges 15% as Cannabis Stocks Rally on Federal Policy Hopes
Tilray Brands leads cannabis sector higher as investors bet on regulatory shifts and improved fundamentals driving sustainable momentum.
Three Cannabis Giants Face Regulatory Crossroads: TLRY, CGC, ACB Compared
Major cannabis operators Tilray, Canopy Growth, and Aurora Cannabis position differently as federal policy shifts loom over the sector's future.
Tilray Stock Plunges: Why Cannabis Giant Fails to Deliver Returns
Despite operating in legal markets, TLRY shares have declined 95% from highs as operational challenges and market dynamics undermine investor expectations.
TLRY Stock Down 95% From Peak: Why Tilray's Cannabis Bet Failed
Tilray Brands has destroyed shareholder value despite operating in legalized markets, highlighting fundamental flaws in cannabis investment thesis.
TLRY Stock Down 90%: Why Tilray's Legal Cannabis Bet Failed Investors
Tilray Brands has destroyed shareholder value despite operating in legal markets, highlighting fundamental flaws in cannabis investment thesis.
Tilray Stock Down 95% From Peak: Why Cannabis Giant Can't Deliver Returns
TLRY shares remain trapped near all-time lows as operational missteps and market realities crush investor expectations in legal cannabis.
TLRY Stock Down 95% From Peak: Why Tilray's Cannabis Strategy Failed
Tilray Brands has destroyed shareholder value despite operating in legal markets, highlighting fundamental flaws in cannabis business models and execution.
Tilray's 96% Decline Exposes Cannabis Investment Reality Check
TLRY stock's massive losses highlight fundamental challenges facing cannabis companies despite legalization progress across multiple markets.
Tilray's Global Expansion Strategy Drives Revenue Diversification
TLRY leverages international cannabis and consumer goods operations to offset domestic headwinds and build sustainable growth platform.